InspireMD reports Q3 growth, buoyed by stent sales and expanded CAS coverage By Investing.com Markets November 6, 2023 [ad_1] © Reuters. InspireMD (NASDAQ:) Inc has reported a robust Q3 2023 efficiency, with an 8.8% enhance in income from…
